Corporate social responsibility in countries with mature and emerging pharmaceutical sectors

Fuente: Redalyc
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Anna VOLODINA
Format: Artículo científico
Sprache:en
Veröffentlicht: Centro de investigaciones y Publicaciones Farmacéuticas 2009
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1876472338241814528
author Anna VOLODINA
author_facet Anna VOLODINA
contents Corporate social responsibility in countries with mature and emerging pharmaceutical sectors Anna VOLODINA Sylvia SAX Stuart ANDERSON Medicina Russia Germany Drug Industry Social Responsibility In recent decades the concept of Corporate Social Responsibility (CSR) has been adopted by many business sectors, including the pharmaceutical industry. However, in this and other sectors its application remains variable, particularly between mature and developing economies. Its stakeholders include pharmacy and medical students, their attitude to the involvement of companies in socially responsible activities will be important determinants of public response to the industry. Objective: To investigate the knowledge, attitudes and practices of senior medical and pharmacy students towards the CSR concept in the pharmaceutical sector in mature (Germany) and developing (Russia) markets. Methods: A questionnaire survey was carried out among senior pharmacy and medical students during the summer semester 2008 in two Russian and one German university. In each country 120 questionnaires were distributed. The response rate was 95% in Russia and 93% in Germany. Results: Although the relevance of CSR was widely acknowledged by the students, very few were aware of CSR practices currently performed by companies. The reputation of the pharmaceutical industry was generally poor: less than 15% of respondents gave credence to the information provided in advertisements and fully supported pricing strategies as well as policies towards the developing countries. When choosing an employer more than 90% of respondents consider the policies affecting an employee directly as pivotal. However, for a high proportion of students (59% in Russia and 64% in Germany) socially irresponsible behavior by companies has a significant negative impact. Conclusions: This paper identifies practices which students believe should be a part of the CSR programmes for the pharmaceutical industry, and also some that should be abandoned. It recommends that corporate communication on CSR should be expanded. Key differences are seen in perceptions of students in Germany and Russia towards the extent of irresponsible actions and the variation between them. 2009 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69015283006 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.4 Vol.7
format Artículo científico
id redalyc_69015283006
institution Redalyc
language en
publishDate 2009
publisher Centro de investigaciones y Publicaciones Farmacéuticas
spellingShingle Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
Anna VOLODINA
Medicina
Russia
Germany
Drug Industry
Social Responsibility
Corporate social responsibility in countries with mature and emerging pharmaceutical sectors Anna VOLODINA Sylvia SAX Stuart ANDERSON Medicina Russia Germany Drug Industry Social Responsibility In recent decades the concept of Corporate Social Responsibility (CSR) has been adopted by many business sectors, including the pharmaceutical industry. However, in this and other sectors its application remains variable, particularly between mature and developing economies. Its stakeholders include pharmacy and medical students, their attitude to the involvement of companies in socially responsible activities will be important determinants of public response to the industry. Objective: To investigate the knowledge, attitudes and practices of senior medical and pharmacy students towards the CSR concept in the pharmaceutical sector in mature (Germany) and developing (Russia) markets. Methods: A questionnaire survey was carried out among senior pharmacy and medical students during the summer semester 2008 in two Russian and one German university. In each country 120 questionnaires were distributed. The response rate was 95% in Russia and 93% in Germany. Results: Although the relevance of CSR was widely acknowledged by the students, very few were aware of CSR practices currently performed by companies. The reputation of the pharmaceutical industry was generally poor: less than 15% of respondents gave credence to the information provided in advertisements and fully supported pricing strategies as well as policies towards the developing countries. When choosing an employer more than 90% of respondents consider the policies affecting an employee directly as pivotal. However, for a high proportion of students (59% in Russia and 64% in Germany) socially irresponsible behavior by companies has a significant negative impact. Conclusions: This paper identifies practices which students believe should be a part of the CSR programmes for the pharmaceutical industry, and also some that should be abandoned. It recommends that corporate communication on CSR should be expanded. Key differences are seen in perceptions of students in Germany and Russia towards the extent of irresponsible actions and the variation between them. 2009 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69015283006 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.4 Vol.7
title Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
topic Medicina
Russia
Germany
Drug Industry
Social Responsibility
url https://www.redalyc.org/articulo.oa?id=69015283006